Wilmington, Delaware, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - TMR study for pseudomonas aeruginosa infection treatment market statistics, estimates a CAGR of 6.6% during the forecast period from 2022 to 2031. Increasing prevalence of pseudomonas aeruginosa, rising awareness about the disease, and robust pipeline of new therapeutics are fuelling the growth of pseudomonas aeruginosa infection treatment market.
According to the WHO, pseudomonas aeruginosa infections are listed under high risk category, and thus the need for treatment to steer future market demand for pseudomonas aeruginosa infections treatment.
Rise in prevalence of nosocomial pseudomonas aeruginosa infections associated with urinary tract infections, pneumonia, and blood stream infections is likely to influence the pseudomonas aeruginosa infection treatment market size. Hospital acquired pseudomonas aeruginosa infection for some patients of COVID-19 led to the demand for pseudomonas aeruginosa infection treatment drugs such as oral ciprofloxacin, to treat both primary and secondary infections.
Increasing incidence of pseudomonas aeruginosa from the use of ventilators and other medical devices, with no effective treatment expands the scope of pseudomonas aeruginosa infection treatment market for novel antibiotics and antibacterial drugs. According to the Centers for Disease Control and Prevention, approximately 51,000 healthcare-related pseudomonas aeruginosa infections occur each year in the U.S. More than 6,000 cases of pseudomonas aeruginosa are multidrug-resistant that is driving leading players in the pseudomonas aeruginosa infection treatment market to develop antibiotics and newer antibacterial drugs.
Get Exclusive PDF Sample Copy of Pseudomonas Aeruginosa Infection Treatment Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17156
Pseudomonas Aeruginosa Infection Treatment Market – Key Findings of the Report
- Combination therapy medication type segment held nearly 74% share of pseudomonas aeruginosa infection treatment market in 2021. Increasing drug resistance of monotherapy, resulting in demand for combination therapy for the treatment of pseudomonas aeruginosa infection is driving growth of the segment.
- Advantages of combination therapy to help increase compliance, efficacy, synergy, and reduced side-effects and cost is leading to increasing uptick in demand. Fast action, cost saving, and high efficiency are some other factors for the rising demand or combination therapy for pseudomonas aeruginosa infection.
- Cephalosporin drug type segment held a key share of approximately 40% of pseudomonas aeruginosa infection treatment market in 2021. Focus of key pharmaceutical companies on the development of new class of cephalosporin for the treatment of pseudomonas aeruginosa boosts the cephalosporin segment. The development of fifth-generation cephalosporin drug for the treatment of gram negative bacteria such as pseudomonas aeruginosa is an example.
- The intravenous segment based on route of administration held key share of nearly 40% of pseudomonas aeruginosa infection market in 2021. Availability of drugs for administering intravenously, high accuracy in dosing, and fast action as compared to other routes of administration stokes demand for intravenous route o administration segment.
- Europe held a key nearly 31% of pseudomonas aeruginosa infection treatment market in 2021. High prevalence of pseudomonas aeruginosa infection treatment market accounts for growth
- North America held nearly 30% of pseudomonas aeruginosa infection treatment market in 2021
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=17156
Pseudomonas Aeruginosa Infection Treatment Market – Growth Drivers
- Need for treatment of pseudomonas aeruginosa listed under the category of high risk diseases boosts the pseudomonas aeruginosa infection treatment market
- Robust clinical trials for new therapeutics for the rapid rise in antibacterial drug resistance underscores growth
Pseudomonas Aeruginosa Infection Treatment Market – Key Players
Some of the key players operating in the pseudomonas aeruginosa infection treatment market are;
- ALLERGAN
- Pfizer Inc.
- AstraZeneca
- Bristol-Myers Squibb Co.
- Teva Pharmaceutical Industries Ltd.
- Lupin Pharmaceuticals Inc.
- Merck & Co. Inc.
- Janssen Pharmaceuticals Inc.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=17156
The pseudomonas aeruginosa infection treatment market is segmented as follows;
Pseudomonas Aeruginosa Treatment Infection Market, by Medication Type
- Monotherapy
- Combination Therapy
Pseudomonas Aeruginosa Treatment Infection Market, by Drug Type
- Aminoglycoside
- Cephalosporin
- Carbapenem
- Monobactam
- Others
Pseudomonas Aeruginosa Treatment Infection Market, by Route of Administration
- Nasal
- Oral
- Intravenous
Pseudomonas Aeruginosa Treatment Infection Market, by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Pseudomonas Aeruginosa Treatment Infection Market, by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Pulmonary Drug Delivery Devices Market: The global pulmonary drug delivery devices market is expected to exceed the value of US$ 49.5 Bn by the end of 2031. It is estimated to grow at a CAGR of 4.7% from 2022 to 2031.
Lactate Meter Market: The global lactate meter market is anticipated to reach more than US$ 299 Mn by the end of 2031. The global market is projected to grow at a CAGR of 8.7% from 2022 to 2031.
Defibrillators Market: The global defibrillator market is expected to cross value of US$ 16.3 Bn by the end of 2031. It is estimated to expand at a CAGR of 8.9% from 2022 to 2031.
Bruise Treatment Market: The global bruise treatment market is anticipated to reach more than US$ 444 Mn by the end of 2031. The global market is projected to expand at a CAGR of 3.5% from 2022 to 2031.
Venous Diseases Treatment Market: Rise in awareness about deep vein thrombosis treatment, chronic venous occlusions treatment, venous insufficiency treatment, and leg ulcer treatment; and growth in number of product approvals are driving the market.
Pressure Ulcers Treatment Market: Rise in prevalence of pressure ulcers, increase in prevalence of chronic diseases, and technological advancements in wound care are anticipated to propel the global pressure ulcers treatment market during the forecast period.
Substance Abuse Treatment Market: Rise in awareness about the negative effects of substance abuse, introduction of new programs, and increase in number of rehabilitation centers globally are expected to contribute to the growth of the global market.
Pericardial Patches Market: The global pericardial patches market is anticipated to reach more than US$ 604 Mn by the end of 2031. The global market is projected to expand at a CAGR of 6.9% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and business consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com
